|
Volumn 51, Issue 4, 2000, Pages 655-672
|
Selective inhibition of arachidonic acid epoxidation in vivo
|
Author keywords
Cytochrome P450; Epoxyeicosanoids; N methylsulphonyl 6 (2 propargyloxyphenyl) hexanamide (MS PPOH); Renal function
|
Indexed keywords
2 HYDROXYPROPYL BETA CYCLODEXTRIN;
ARACHIDONIC ACID;
CYTOCHROME P450;
CYTOCHROME P450 INHIBITOR;
EPOXYICOSATRIENOIC ACID;
N METHYLSULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARACHIDONIC ACID METABOLISM;
BLOOD VESSEL TONE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG INHIBITION;
EPOXIDATION;
IN VIVO STUDY;
KIDNEY FUNCTION;
MALE;
NONHUMAN;
POTASSIUM EXCRETION;
RAT;
SODIUM EXCRETION;
URINARY EXCRETION;
URINE FLOW RATE;
8,11,14-EICOSATRIENOIC ACID;
AMIDES;
ANIMALS;
ARACHIDONIC ACID;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYCLODEXTRINS;
CYTOCHROME P-450 ENZYME SYSTEM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME INHIBITORS;
FATTY ACIDS, UNSATURATED;
HUMANS;
IMMUNOBLOTTING;
KIDNEY;
MALE;
MICONAZOLE;
MICROSOMES;
ORGANOPHOSPHORUS COMPOUNDS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECOMBINANT PROTEINS;
SULFONES;
|
EID: 0034519059
PISSN: 08675910
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (39)
|
References (51)
|